Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation. Journal of Neuroimmunology, 330, 90-95. https://doi.
A C C E P T E D M A N U S C R I P T
Introduction
Perfluorinated alkylated substances (PFASs) are synthetic chemical compounds produced since the 1950s. PFASs are substances with long carbon chains with fluorine atoms replacing the hydrogen atoms. Carbon-fluorine bindings are very stable, and biodegradation of PFASs is extremely slow (Li et al. , 2018) . Much focus has been on the "long-chain" PFASs as the toxicity and accumulation in the environment seems to increase with the length of the carbon chains. PFASs have been used as surfactants in a wide range of consumer products due to their combined hydrophilic and hydrophobic properties and has for the last two decades been investigated for their potential harmful effects in humans (Buck et al. , 2011) . Human exposure to PFASs stem from inhaled particles and from contaminated food products and drinking water due to a lack of environmental degradation (ATSDR, 2018) .
In humans, PFASs are only slowly eliminated, and serum half-lives of up to 5.4 years are reported (Li, Fletcher, 2018 , Stahl et al. , 2011 . PFASs bind to serum proteins and accumulate in kidneys, liver and blood (Jian et al. , 2018) . Mostly shorter chain
PFASs are found to be excreted in urine whereas long-chain PFASs are suggested to be excreted through breast milk and blood (Fromme et al. , 2009 , Lorber et al. , 2015 , Wong et al. , 2014 . Reported health effects from PFASs includes several studies suggesting an immunosuppressive or immunotoxic effect of PFASs (DeWitt et al. , 2018 , Grandjean et al. , 2017a , Stein et al. , 2016 .
A C C E P T E D M A N U S C R I P T
Multiple sclerosis (MS) is an immune-mediated disease in the central nervous system (CNS) . The disease is driven by autoimmune cells recruited from the periphery causing disease upon entry to the CNS (Compston and Coles, 2008, Sospedra and Martin, 2016) . Genetic and environmental factors are believed to be main contributors to the etiology of MS. Some of the strongest risk factors reported are female sex, smoking, low vitamin D, Epstein-Barr virus (EBV) infection, and carrying the HLA-DRB1*15:01 risk gene (Belbasis et al. , 2015 , Duan et al. , 2014 , Handel et al. , 2011 Multiple Sclerosis Genetics and The Wellcome
Trust Case Control, 2011).
One study has reported a slightly increased occurrence of MS at highly elevated exposures to perfluorooctanoic acid (PFOA), but the association between serum-PFOA concentrations and MS was not statistically significant (Steenland et al. , 2013) . However, the serum concentration obtained may not have reflected the pathogenic exposure. To our knowledge, effects of PFASs on MS risk factors and circulating immune cell characteristics are poorly known.
Accordingly, we aimed to investigate if serum-PFAS concentrations are associated with MS and to further examine the impact of PFASs and known MS risk factors on the relative distribution and activation of circulating immune cells.
Methods

Study population
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Serum concentrations of PFASs were measured in 86 out of 100 healthy controls (HC) from whom we had collected blood samples and obtained data on immune cell frequencies and activation in a previous study (Ammitzboll et al. , 2017) and 76 patients of whom 67 were diagnosed with relapsing-remitting MS (RRMS), and 9 with a clinically isolated syndrome (CIS). All patients were untreated at the time of blood sampling. From the RRMS patient cohort, 51 patients were newly diagnosed and untreated and 16 patients had not received immunomodulatory or immunosuppressive treatment for at least two months. All patients were diagnosed according to the 2010 McDonald criteria (Polman et al. , 2011) . All samples were collected within a 2-year period and we found no significant correlation with PFAS concentrations and sample date in neither HC nor patients with MS (supplementary figure 1). Information of number of children, duration of menstruation and breastfeeding were obtained by questionnaires.
All participants provided informed consent to study participation. Ethical approval was obtained from the local scientific ethics committee.
Methods
PFAS mass spectrometry
Analysis of the per fluorinated alkylated substances (PFOA: perfluorooctanoic acid;
PFNA: perfluorononanoic acid; PFDA: perfluorodecanoic acid, PFHxS:
Perfluorohexane sulfonic acid, PFHpS: perfluoroheptane sulfonic acid and PFOS:
A C C E P T E D M A N U S C R I P T perfluorooctane sulfonic acid) were performed in serum using on-line solid phase extraction followed by Liquid Chromatography and tandem mass spectrometry (LC-MS/MS) as previously described (Grandjean et al. , 2012 , Haug et al. , 2009 
ELISA and Electrochemiluminescence Protein Binding Assay
Anti-EBNA-1 antibodies and cotinine concentrations were measured by ELISA assays (Diasorin, Italy and Calbiotech, USA) as previously described in detail (Ammitzboll, Bornsen, 2017) . 25-hydroxyvitamin D concentrations were analyzed at the Department of Clinical Biochemistry, Rigshospitalet, University hospital of Copenhagen, using electrochemiluminescence protein binding assays on a COBAS 8000 analyzer.
HLA-DRB1*15:01 genotyping
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DNA extracted from buffy coats was genotyped by PCR assays using TaqMan® allelic discrimination according to manufacturer (Life Technologies, Denmark). SNP rs9271366 was used to tag HLA-DRB1*15:01 as previously described (Ammitzboll, Bornsen, 2017) .
Flow cytometry on circulating cells
Peripheral blood mononuclear cells (PBMCs) were isolated from freshly drawn blood samples using Lymphoprep (Axis-Shield, Norway) and density gradient centrifugation. PBMCs were washed and added FcR Blocking Reagent (Miltenyi Biotec, Germany). PBMCs were then stained with anti-CD14, CD1c, BDCA2, CD19, CD40, CD80, CD83, CD86, CD27, CD38, DC-Sign, ICOSL, CD3, CD4, CD8, CD45RA, CD62L, CCR6, CXCR3, CXCR5, ICOS, IL23R, CD26, CD161, CD25, CD127, CD31 and CD39. Data were acquired on a FACS Canto II (BD Biosciences, USA) and FlowJo (Tree star, USA) and FACS Diva software (BD Biosciences, USA) were used for data analyses as previously described in details (Ammitzboll, Bornsen, 2017) . Intracellular cytokine staining was done by re-stimulating the PBMCs with phorbol 12-myristate 13 acetate (PMA; 10ng/mL, Sigma-Aldrich, USA) and ionomycin (0.5 µg/mL, Sigma-Aldrich, USA) for 30 minutes and then incubating the cells for 4 hours with Brefeldin A (5µg/ml, Sigma-Aldrich, USA). Cells were then stained with anti-CD3 and CD8, and a live/dead stain and fixed and permeabilized according to manufacturer's protocol (Fixation Buffer and Permeabilization Buffer, Biolegend, USA). PBMCs were then stained with anti-IL-17A, IFNγ and GM-CSF and analyzed by flow cytometry as previously described (Ammitzboll, Bornsen, 2017) .
T cell activation assays
Statistical analyses
Statistics on PFOS concentrations were performed using parametric analyses of logarithmically transformed values. We used Pearson's correlation analyses, analyses of covariance (ANCOVA) and multiple linear regression analyses using the "forced entry" method. Analyzing cell frequencies was done using non-parametric methods since many of the cell frequencies were not suitable for parametric analyses even in a
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transformed form. Mann-Whitney's U test and Spearman's rank correlation analyses were performed. We used a significance level of P < 0.005 and did not correct for multiple testing (Benjamin et al. , 2018) .
Results
One hundred HC and 76 patients with RRMS or CIS were included in the study.
Demographics are shown in table 1. From 86 HC and from all 76 patients, we obtained serum concentrations of six long-chain PFASs: the per fluorinated alkylated sulfonic acids perfluorohexane sulfonic acid (PFHxS) (C6), perfluoroheptane sulfonic acid (PFHpS) (C7) and perfluorooctane sulfonic acid (PFOS) (C8); and the perfluoroalkyl carboxylic acids perfluorooctanoic acid (PFOA) (C 7 ), perfluoro nonanoic acid (PFNA) (C 8 ) and perfluorodecanoic acid (PFDA) (C 9 ).
To identify demographic factors related to PFASs in the blood, we initially studied correlations of age, years of menstruation, number of children, total months of breastfeeding and sex with PFASs in the HC cohort (supplementary 
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between serum-PFAS concentrations in men and women was non-significant when adjusting for age, breastfeeding, years of menstruation and number of children (data not shown). All serum-PFAS concentrations were closely correlated (P < 0.0001).
To determine if PFAS exposure is related to MS, we performed multiple regression analyses. We found that only PFOS concentrations differed significantly between HC and patients with MS or CIS (table 2) . These analyses were adjusted for sex, age and breastfeeding. Age was more closely associated with PFOS concentrations than years of menstruation, and the latter was therefore not included as covariate. Likewise, number of children showed collinearity with duration of breastfeeding. Because women with and without MS had comparable number of children, the variable was therefore excluded from the analysis (table 1) 
We did not find significant associations between PFOS concentrations and any of the circulating immune cell types, T cell activation or cytokine producing T cells, but we did see a tendency of circulating CD8+ T cells being skewed towards a memory phenotype (supplementary table 3 ). Cotinine concentrations, as a measure of smoking intensity, has previously been explored in a sub-group analysis of HC (Ammitzboll, Bornsen, 2017) . We confirm our previous findings of lower frequencies of CD8+ T cells characterized by the expression of CD26 hi CD161 hi in smokers, presumably defining mucosal associated invariant T (MAIT) cells (Ammitzboll, Bornsen, 2017 , Sharma et al. , 2015 , and increased percentages of ICOSL+ plasmacytoid dendritic cells (pDC). Furthermore, cotinine was positively correlated with the percentage of 3 ). Anti-EBNA-1 were not associated with CD4+ T cell proliferation.
Carriers of the MS risk allele HLA-DRB1*15:01 among HC did not have increased frequencies of any of the studied circulating immune cell types or increased proliferating or cytokine producing T cells. We found a tendency (P = 0.007) to higher frequencies of circulating CD80+ B cells in HC who did not carry the risk allele (supplementary table 3 ).
Discussion
With the present study, we show novel data on the cross-sectional relationship between PFAS exposure and RRMS and conclude that RRMS is associated with lower serum concentrations of PFOS compared with HC, whereas we found no difference for the other PFASs studied after adjustment for relevant confounding factors.
Being one of the largest PFAS, PFOS is poorly eliminated from the human body.
Consequently, the health problems associated with PFOS exposure, as compared with other PFASs, have attracted the most attention. Early-life exposure to PFOS was previously found to be associated with poor antibody responses in children upon vaccination, and a high MS prevalence was reported in an area of high exposure of PFOA, another long chain PFAS (Grandjean, Andersen, 2012 , Grandjean et al. , 2017b , Steenland, Zhao, 2013 . Based on this information, we speculated that PFAS We did not find serum-PFOS associated with known MS risk factors and we were not able to identify an effect of PFOS on circulating immune cells. However, we relied on blood samples from HC and we cannot rule out that an effect of PFOS on immune cells may occur in patients with MS. Pregnancy, breastfeeding and blood loss are some of the important elimination routes of PFASs. We have tried to adjust for confounding factors influencing serum concentrations of PFOS. However, for number of children we did not know if some children were adopted and we were not able to quantify the loss of blood due to menstruation. Moreover, we do not have information on blood donation or other significant sources of blood loss in the cohorts.
Investigations of the influence of MS risk factors on circulating and activated
immune cells were explorative and we did not adjust for multiple testing.
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Accordingly, we used a significance level of P < 0.005, but the results should be validated in an independent cohort.
We found that women have more CD4+ T cells but less IL-21 secreting CD4+ T cells. Higher frequencies of circulating CD4+ T cells in women might be part of the reason why women are more susceptible to developing MS, as autoreactive CD4+ T cells are believed to be major players in MS pathogenesis (Sospedra and Martin, 2005) . Higher frequencies of IL-21 producing CD4+ T cells in men are difficult to interpret. IL-21 has immunomodulatory roles and is most often considered to induce pro-inflammatory immune responses. However, the effect in MS is controversial (Ghalamfarsa et al. , 2016) .
Not surprisingly, age was associated with more antigen-experienced CD8 T cells.
Increased frequencies of CD39+ T reg cells with age is previously described (Ruhnau et al. , 2016) . CD39+ T reg cells are described as having suppressor functions on effector T cells and, in MS, an impaired IL-17 suppression by CD39+ T reg cells has been found (Fletcher et al. , 2009 ). The lower frequencies of IFN-γ producing antigen-reactive CD4+ T cells could possibly reflect a less aggressive circulating T cell pool with higher age. MS is primarily affecting younger adults (Filippi et al. , 2018) , but whether this is related to a protective effect of circulating CD39+ T reg cells with higher age and more easily activated CD4+ T cells with young age is highly speculative.
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We confirm that smoking is associated with fewer circulating MAIT-like cells using cotinine as a measure of smoking intensity. The role of MAIT cells in MS is yet undetermined (Ammitzboll, Bornsen, 2017) . MAIT cells are found in MS brains but frequencies in blood of patients with MS are reported with contradictory results (Annibali et al. , 2011 , Illes et al. , 2004 , Miyazaki et al. , 2011 , Willing et al. , 2014 .
A recent study reports a more pro-inflammatory MAIT cell profile in patients with MS than HC (Willing et al. , 2018) . Accordingly, MAIT cells have been associated with both proinflammatory and protective functions in MS (Treiner and Liblau, 2015) . The lower MAIT-like cell frequency we found in smokers might be suggestive of cells migrating to the lung mucosa of smokers, but how and if this worsens MS disease is highly speculative.
We also found increased co-stimulatory molecules ICOSL and CD86 on antigen presenting cells, pDCs and B cells from smokers. Both molecules are essential in T cell activation and whereas ICOSL is specifically upregulated on mature pDCs, CD86 is universal on antigen presenting cells (Ito et al. , 2007 , Janke et al. , 2006 .
ICOSL-ICOS interaction are furthermore important for the development of Tfh cells (Fan et al. , 2015) . Our group has previously found increased frequencies of ICOS+ Tfh cells in patients with RRMS. Other research groups support this finding (Cunill et al. , 2018 , Romme Christensen et al. , 2013 , Shekhar and Yang, 2012 . In this study, we did not find increased frequencies of ICOS+ Tfh cells in HC smokers.
Overall, smoking seems to induce antigen presenting cells with higher T cell activation properties.
Vitamin D concentrations seemed generally associated with a CCR6+ CD4+ T cell phenotype in resting and activated T cells. In MS, vitamin D is generally agreed to have a protective effect (Duan, Lv, 2014) . Since CCR6+ CD4+ T cells are suggested to be MS-pathogenic, we would have expected CCR6+ CD4+ T cells to be negatively correlated with vitamin D concentrations. This is further supported by findings in autoimmune diseases of vitamin D inhibiting CCR6 gene expression in activated CD4+ T cells (Dankers et al. , 2016) . Our findings of higher vitamin D concentrations related to a CCR6+ phenotype on resting, non-proliferating CD4+ T cells could be explained by the fact that we studied HC and therefore reflect a healthy condition. This is supported by findings of vitamin D being essential for T cell activation (von Essen et al. , 2010) .
Anti-EBNA-1 concentrations were associated with IFN-γ and GM-CSF production in CD4+ T cells resting in culture for seven days. Anti-EBNA-1 also were found to be associated with lower ICOS+ Tfh and higher CD8 CM T cell frequencies. Previous studies have shown that patients with MS have more EBNA-1 specific CD4+ T cells than HC and that these cells are predominantly of a Th1 cell type (Lunemann et al. , 2008) . This is consistent with our findings in HC as IFN-γ secretion defines Th1
cells. Frequencies of T cells secreting GM-CSF also have previously been found to
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be higher in patients with MS compared with HC and is associated with MS severity biomarkers (Hartmann et al. , 2014 , Rasouli et al. , 2015 . The lower frequencies of ICOS+ Tfh with increasing anti-EBNA-1 concentrations suggest an overall skewed Th1/Tfh ratio with increasing concentrations of anti-EBNA-1.
In conclusion, we were not able to support PFAS exposure as an environmental risk factor for MS. Conversely, our findings suggest a potential protective effect of serum-PFOS concentrations on MS which may be attributed to an immunosuppressive effect of PFOS. However, we were not able to characterize any such effect in our detailed immuno-phenotype study. From studying already known MS risk factors and their effect on immune cell mechanisms, we confirm the suppressing effect of smoking on circulating MAIT-like cells as well as the linkage between EBV infection and GM-CSF and IFN-γ producing CD4+ T cells. These findings add to the importance of studying the effect of MS risk factors in healthy controls and its capacity to provide mechanistic insights into the pathogenesis of complex immune-mediated diseases such as MS.
The following are the supplementary data related to this article.
Supplementary figure 1. PFAS concentrations depictured with time.
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